Heterogeneity of p53-pathway Protein Expression in Chemosensitive Chronic Lymphocytic Leukemia: A Pilot Study

The presence of p53-pathway dysfunction in chronic lymphocytic leukemia (CLL) can be used to identify patients with chemotherapy-refractory disease. Therapeutic responses are known to vary between patients with chemosensitive CLL and may relate to differences in p53-pathway activity. We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Groves, Michael J, MacCallum, Stephanie F, Boylan, Michael T, Haydock, Sally, Cunningham, Joan, Gelly, Keith, Gowans, Duncan, Kerr, Ron, Coates, Philip J, Tauro, Sudhir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434363/
https://www.ncbi.nlm.nih.gov/pubmed/22962562
http://dx.doi.org/10.7150/jca.4813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434363/
https://www.ncbi.nlm.nih.gov/pubmed/22962562
http://dx.doi.org/10.7150/jca.4813

Ejemplares similares